Public COA audit

Ipamorelin · Ipamorelin - 10mg

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
93%
Panels
3/7
Purity (printed)
99.9%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
IP10617RONG
Identity method
HPLC-RTM
Sample date
2026-07-01
Issue date
2026-07-13

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.90%

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    Not Detected

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity confirmed

    99.90% purity by HPLC with clean chromatogram showing single major peak, consistent with high-quality research peptide

  • Identity confirmed by HPLC-RTM

    Ipamorelin identity verified using retention time matching

  • Complete batch information

    Lot number IP10617RONG, 10mg labeled content, 3mL vial size clearly documented

  • Recent testing dates

    Sample received 2026-07-01, analysis date 2026-07-13, both within normal timeframes

  • Professional laboratory presentation

    ILS Laboratories with complete contact information, accreditation logos (ISO/IEC 17025), signatory Dr. Greg Kalyuzhny, verification URL and QR code provided

  • Limited testing scope

    Only purity, identity, and fentanyl screening performed. No heavy metals, microbial, sterility, or residual solvent testing documented

  • Fentanyl screening included

    Unusual but positive safety measure - fentanyl immunoassay screen performed and passed (not detected)

  • Professional document structure

    Well-formatted COA with clear sections, HPLC chromatogram included, methodology notes provided, proper header/footer with page numbering

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.